Who invested in NEUmiRNA?
3 investors are on record as having backed NEUmiRNA — Developing therapies for neurological diseases, in Biotech, Denmark. Each row below says whether the round came from the investor's own portfolio page or from the press.
neumirna.comNEUmiRNA investors
Sunstone CapitalInvests in early-stage life science companies developing novel therapeutics.series-a$20MJan 2025press
Angelini VenturesInvests in BioTech and HealthTech companies transforming healthcare with data-driven…their site
1 more investors on record for NEUmiRNA.
The first two are open to everyone. A free account opens the rest — the fund, the round, the amount and where each number came from. No card, no demo call.
The funds that backed NEUmiRNA are in the directory.
If they wrote this cheque, they may write yours. Pitch2Fund scores your startup against every one of them, gives you the partner to write to, and drafts the email. Free.